Umeclidini: tractament broncodilatador de manteniment per alleujar els símptomes de la malaltia pulmonar obstructiva crònica en pacients adults
Abstract
Umeclidini is a LAMA plus for the maintenance of COPD moderate to very serious. Its impact on the prevention of exacerbations is unknown and has not shown to be clinically superior to tiotropy in the improvement of pulmonary function, in the reduction of the symptoms or in the improvement of the quality of life. Therefore, it is recommended to continue using the reference bronchodilators treatments (tiotropes, salmeterol and formoterol)
Keywords
Chronic obstructive lung disease; Bronchodilators long-term; Exacerbations
Bibliographic citation
Umeclidini: tractament broncodilatador de manteniment per alleujar els símptomes de la malaltia pulmonar obstructiva crònica en pacients adults. Barcelona: Servei Català de la Salut, 2017.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/3507This item appears in following collections
The following license files are associated with this item: